CTOR · Citius Oncology, Inc. · Debt
$0.87
0.00 (-0.47%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital to support our operations beyond November 2026, which raises substantial doubt about our ability to continue as a going concern within one year after the date that the accompanying financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$94.92M
Shares
92.98M
Volume · Oct 6
72.08K
Avg daily vol (3M)
99.78K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Noncurrent finance lease liabilities | 2026-06-30 | USD 6,410,161 | 10-Q filed 2026-08-14 |
| Noncurrent notes payable | 2026-06-30 | USD 6,410,161 | 10-Q filed 2026-08-14 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.